MedTrace Logo

Prevention of Mood Disorders by Folic Acid Supplementation

NCT00459264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2016-11-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily folic acid supplements can prevent new episodes of mood disorder in young people (aged 14-24 years) of biological parents with current or past history of depression or bipolar disorder.

Conditions

Interventions

DRUG

Folic Acid

Folic acid oral solution 2.5mg/5ml daily for up to 3 years

DRUG

Placebo

Matching placebo for folic acid oral solution (2.5mg/5ml)

Sponsors & Collaborators

  • Stanley Medical Research Institute

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • John R Geddes, MD FRCPsych · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2011-06-30
Completion
2011-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00459264 on ClinicalTrials.gov